Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (101-110 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|April 1, 1985
Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragmentsA Racanelli, J Fareed, J M Walenga, et al.
Radiology|May 1, 1991
Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast mediaJ F Mamon, D Hoppensteadt, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.
The Annals of Thoracic Surgery|May 1, 1992
Hemostatic abnormalities in total artificial heart patients as detected by specific blood markersJ M Walenga, D Hoppensteadt, J Fareed, et al.
Thrombosis Research|December 1, 1981
Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assayZ Parvez, J Fareed, H L Messmore, et al.
Thrombosis Research|January 15, 1991
Lack of inhibition of thrombin generation by nonionic contrast mediaJ F Mamon, J Fareed, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1991
Report on a discussion forum: "Medical and surgical application of recombinant hirudin"J M Walenga, F Markwardt, K Breddin, et al.
Haemostasis|January 1, 1986
Biochemical and pharmacological studies on the interaction of PK 10169 and its subfractions with human plateletsL D Brace, J Fareed, J Tomeo, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Synthetic and recombinant antithrombin drugsB Kaiser, D Callas, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparinD Hoppensteadt, A Racanelli, J M Walenga, et al.
Pageof 39

Showing results (101-110 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|April 1, 1985
Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragmentsA Racanelli, J Fareed, J M Walenga, et al.
Radiology|May 1, 1991
Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast mediaJ F Mamon, D Hoppensteadt, J Fareed, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.
The Annals of Thoracic Surgery|May 1, 1992
Hemostatic abnormalities in total artificial heart patients as detected by specific blood markersJ M Walenga, D Hoppensteadt, J Fareed, et al.
Thrombosis Research|December 1, 1981
Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assayZ Parvez, J Fareed, H L Messmore, et al.
Thrombosis Research|January 15, 1991
Lack of inhibition of thrombin generation by nonionic contrast mediaJ F Mamon, J Fareed, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1991
Report on a discussion forum: "Medical and surgical application of recombinant hirudin"J M Walenga, F Markwardt, K Breddin, et al.
Haemostasis|January 1, 1986
Biochemical and pharmacological studies on the interaction of PK 10169 and its subfractions with human plateletsL D Brace, J Fareed, J Tomeo, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Synthetic and recombinant antithrombin drugsB Kaiser, D Callas, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparinD Hoppensteadt, A Racanelli, J M Walenga, et al.
Pageof 39